These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 20959468

  • 21. The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors.
    Coelho RP, Payne SG, Bittman R, Spiegel S, Sato-Bigbee C.
    J Pharmacol Exp Ther; 2007 Nov; 323(2):626-35. PubMed ID: 17726159
    [Abstract] [Full Text] [Related]

  • 22. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720.
    Zemann B, Kinzel B, Müller M, Reuschel R, Mechtcheriakova D, Urtz N, Bornancin F, Baumruker T, Billich A.
    Blood; 2006 Feb 15; 107(4):1454-8. PubMed ID: 16223773
    [Abstract] [Full Text] [Related]

  • 23. FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
    Li MH, Hla T, Ferrer F.
    Pediatr Blood Cancer; 2013 Sep 15; 60(9):1418-23. PubMed ID: 23704073
    [Abstract] [Full Text] [Related]

  • 24. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y, Dalrymple SL, Becker RE, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 2006 Jul 01; 12(13):4072-9. PubMed ID: 16818707
    [Abstract] [Full Text] [Related]

  • 25. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C, Zieher H, Roth A, Hauser K, Lipson KE, Weber KJ, Debus J, Abdollahi A, Huber PE.
    Clin Cancer Res; 2008 Apr 01; 14(7):2210-9. PubMed ID: 18381963
    [Abstract] [Full Text] [Related]

  • 26. Effect of FTY720 on apoptosis of smooth muscle cells.
    Böhler T, Guillebaud J, Etienne L, Canivet C, Kamar N, Rostaing L, Thiers JC, Galvani S, Augé N, Salvayre R, Nègre-Salvayre A, Thomsen M.
    Transplant Proc; 2007 Oct 01; 39(8):2624-6. PubMed ID: 17954194
    [Abstract] [Full Text] [Related]

  • 27. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR, Bot M, Brodde M, Taylor PJ, Salm P, Brinkmann V, van Berkel T, Assmann G, Biessen EA.
    Circulation; 2007 Jan 30; 115(4):501-8. PubMed ID: 17242282
    [Abstract] [Full Text] [Related]

  • 28. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis.
    Dev KK, Mullershausen F, Mattes H, Kuhn RR, Bilbe G, Hoyer D, Mir A.
    Pharmacol Ther; 2008 Jan 30; 117(1):77-93. PubMed ID: 17961662
    [Abstract] [Full Text] [Related]

  • 29. Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues.
    Högenauer K, Billich A, Pally C, Streiff M, Wagner T, Welzenbach K, Nussbaumer P.
    ChemMedChem; 2008 Jul 30; 3(7):1027-9. PubMed ID: 18383466
    [No Abstract] [Full Text] [Related]

  • 30. FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma.
    Lee TK, Man K, Ho JW, Wang XH, Poon RT, Xu Y, Ng KT, Chu AC, Sun CK, Ng IO, Sun HC, Tang ZY, Xu R, Fan ST.
    Clin Cancer Res; 2005 Dec 01; 11(23):8458-66. PubMed ID: 16322309
    [Abstract] [Full Text] [Related]

  • 31. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N, Benning CM.
    Cancer Res; 2000 Aug 15; 60(16):4550-5. PubMed ID: 10969806
    [Abstract] [Full Text] [Related]

  • 32. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 15; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

  • 33. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.
    Tonelli F, Lim KG, Loveridge C, Long J, Pitson SM, Tigyi G, Bittman R, Pyne S, Pyne NJ.
    Cell Signal; 2010 Oct 15; 22(10):1536-42. PubMed ID: 20570726
    [Abstract] [Full Text] [Related]

  • 34. Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b.
    Lim KG, Tonelli F, Berdyshev E, Gorshkova I, Leclercq T, Pitson SM, Bittman R, Pyne S, Pyne NJ.
    Int J Biochem Cell Biol; 2012 Sep 15; 44(9):1457-64. PubMed ID: 22634604
    [Abstract] [Full Text] [Related]

  • 35. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.
    Paugh SW, Payne SG, Barbour SE, Milstien S, Spiegel S.
    FEBS Lett; 2003 Nov 06; 554(1-2):189-93. PubMed ID: 14596938
    [Abstract] [Full Text] [Related]

  • 36. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
    Zhang X, Deng HX, Zhao X, Su D, Chen XC, Chen LJ, Wei YQ, Zhong Q, Li ZY, He X, Yi T.
    Oncology; 2009 Nov 06; 77(1):22-32. PubMed ID: 19440000
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y, Ma Y, Lu HP, Gao JH, Liang CS, Liu CZ, Zou JT, Wang HQ.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2284-9. PubMed ID: 19080333
    [Abstract] [Full Text] [Related]

  • 38. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE, Jung CG, Kim HJ, Kennedy TE, Soliven B, Antel JP.
    Ann Neurol; 2008 Jan 20; 63(1):61-71. PubMed ID: 17918267
    [Abstract] [Full Text] [Related]

  • 39. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.
    Li W, Li J, Wang Y, Zhang K, Li N, Tian Z, Ni B, Wang H, Ruan Z.
    Oncotarget; 2016 Dec 06; 7(49):80586-80598. PubMed ID: 27811359
    [Abstract] [Full Text] [Related]

  • 40. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
    Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R.
    Clin Cancer Res; 2002 Nov 06; 8(11):3512-9. PubMed ID: 12429642
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.